LONDON, June 24 /PRNewswire/ -- Pulse oximetry is often referred to as the fifth vital sign. The significance of continuous oxygenation monitoring in hospitals and other critical care settings cannot be doubted. Pulse oximetry technology has undergone considerable change over the past couple of years and recent advances have made the process not only more reliable and safer but also more accurate. However, the pulse oximetry market faces the same challenges that are crippling the total patient monitoring market.
(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)
New analysis from Frost & Sullivan (http://www.patientmonitoring.frost.com), European Pulse Oximetry Market, finds that the market earned revenues of $150 million in 2008 and estimates this to reach $246 million in 2015. In this research, Frost & Sullivan's expert analysts thoroughly examine the stand-alone and hand-held devices product sectors for hospitals and alternate care units.
If you are interested in a virtual brochure, which provides a brief synopsis of the research and a table of contents, then send an e-mail to Katja Feick, Corporate Communications, at katja.feick@frost.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, a brochure will be sent to you by e-mail.
"In the past decade, several long-term trends have emerged, which have driven the need for more advanced patient care in the intermediate and sub-acute are
'/>"/>
| SOURCE Frost & Sullivan Copyright©2009 PR Newswire. All rights reserved |